A British medical regulator in Britain reported that some people had a rare blood clot formed in their brain after AstraZeneca’s coronavirus vaccine (AstraZeneca coronavirus). The ‘Medicine and Healthcare Product Regulatory Agency’ (MHRA) said that 1.1 crore British citizens had the AstraZeneca vaccine. Of these, five people have seen symptoms of ‘Cerebral Sinus Vein Thrombosis’ (CSVT). These cases have been seen in men, whose age is between 19 and 59.
According to the UK regulator, CSVT is such a rare disease that experts are not yet sure how common it is in the general population. MHRA head doctor June Ren said, the cases of blood clotting in the vaccinated patients may have been due to the corona itself rather than the vaccine. John Hopkins University has estimated that out of one million people in the US, five cases of CSVT are reported every year. At the same time, 360 patients are affected by CSVT every year in the UK.
No evidence between CSVT and AstraZeneca vaccine
According to John Hopkins University, CSVT has a greater effect on patients suffering from low blood pressure, cancer, blood clotting. This disease can also happen due to head injury. MHRA stated that there is no evidence yet that there is a connection between the CSVT and the AstraZeneca vaccine. In its review, MHRA noted that the risk of dying from corona in most people is at least 1,000 times higher, which means that getting the vaccine is by far the safest option.
What is CSVT?
Europe’s drug watchdogs have found cases of CSVT among 13 people vaccinated in the continent. CSVT occurs when the veins carrying blood from the brain get blocked due to blood clots. This causes blood to flow inside the brain. The hallmark of this disease is that the first patient has a headache. Then he starts looking blurred and soon becomes insensitive. Due to lack of treatment at the right time, a person can also die.
.